4//SEC Filing
Nelson Christopher M. 4
Accession 0001493152-23-022262
CIK 0001310527other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:30 PM ET
Size
11.1 KB
Accession
0001493152-23-022262
Insider Transaction Report
Form 4
Nelson Christopher M.
DirectorCEO
Transactions
- Award
Common Stock
2023-06-23+46,365→ 173,317 total
Holdings
- 255
Options to buy common stock
Exercise: $20.00From: 2014-07-31Exp: 2024-07-31→ Common Stock (255 underlying) - 12,500
Options to buy common stock
Exercise: $10.00Exp: 2032-03-03→ Common Stock (12,500 underlying) - 2,875
Options to buy common stock
Exercise: $14.40Exp: 2031-08-23→ Common Stock (2,875 underlying) - 60
Options to buy common stock
Exercise: $20.00From: 2015-11-18Exp: 2025-11-18→ Common Stock (60 underlying) - 4,557
Series B
Footnotes (4)
- [F1]This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
- [F2]Represents shares of Common Stock receivable upon conversion of Series B Preferred Stock at a conversion rate of $5.42 per share, and includes accrued dividends as of 05/31/2023.
- [F3]The option vests annually in two equal installments beginning on 3/3/2023.
- [F4]The option vests semi-annually in two equal installments beginning on 2/24/2022
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001529012
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:30 PM ET
- Size
- 11.1 KB